Fidelity Hedged Equity Central Fund VRTX Holdings History
Fidelity Hedged Equity Central Fund's Vertex Pharmaceuticals Inc Holding Summary
As of 2024-04-30, Fidelity Hedged Equity Central Fund held - shares of Vertex Pharmaceuticals Inc(VRTX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Fidelity Hedged Equity Central Fund now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.
The initial trade took place in 2023Q1. And since then Fidelity Hedged Equity Central Fund has made 3 purchases of VRTX, at an average price of $336.94, for a total of 4,655.00 shares. In addition, there have been 2 sales at an average price of $405.98 for 4,655.00 shares. Based on historical transaction data and VRTX's current price of $476.60, Fidelity Hedged Equity Central Fund's estimated gain on his VRTX holdings is $321,364.12, reflecting a 20.49% gain to date.
Fidelity Hedged Equity Central Fund VRTX ($476.60) Holding Chart
Fidelity Hedged Equity Central Fund VRTX ($476.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
